Prenetics has launched a blockchain-based identity verification partnership with Humanity Protocol through its flagship CircleDNA service
Genomics and consumer healthcare company Prenetics Global Limited has announced its genome-based partnership with Humanity Protocol to bring genetics onto the blockchain.
The collaboration leverages Prenetics’s advanced genetic testing capabilities to underpin decentralised identity verification, and both parties unveiled a Crypto Strategic Reserve to fuel innovation in blockchain, healthcare, and decentralised science (DeSci).
Prenetics has committed initial investments of US$1 million in $H tokens, $250,000 in Bitcoin (BTC), and $250,000 in Solana (SOL). As an Identity Validator, Prenetics will be integrating its CircleDNA service into the protocol’s infrastructure.
Danny Yeung, CEO and Co-Founder of Prenetics, stated: “Our partnership with Humanity Protocol exemplifies our commitment to merging the precision of genomics with the transformative potential of blockchain technology. Through our CircleDNA service, we will provide secure, privacy-focused identity solutions that not only benefit decentralised applications across finance, healthcare, and governance but also pave the way for further integration of digital assets into our strategic framework.”
“Blockchain is creating unprecedented opportunities for innovation across industries,” said Yeung. “By merging the rigor of genomics with digital innovation, we are forging a path toward a future where secure identity verification and groundbreaking healthcare solutions go hand in hand.”
Yat Siu, Board Director of the Humanity Foundation and Executive Chairman of Animoca Brands, added: “Prenetics’s entry into the decentralized identity arena as an Identity Validator marks a significant milestone. Their deep expertise in genomics, now combined with an active role in the Web3 ecosystem, is exactly the kind of forward-thinking collaboration that will drive decentralised identity and secure digital interactions into the future.”
